About this trial
aims to compare the efficacy of the posterior pericardial window versus retro-cardiac drain in preventing postoperative atrial fibrillation and pericardial complications following CABG, while assessing their impact on hospital and ICU stay, pericardial effusions, re exploration for bleeding, post-operative blood transfusions, and mortality.
Eligibility criteria
Qualifiers
Adult patients (aged 18 and above) scheduled for elective, first-time coronary artery bypass grafting (CABG).
Patients with preserved left ventricular function (ejection fraction ≥ 35%).
Ability to provide informed consent and comply with follow-up protocols.
No prior history of atrial fibrillation or other significant arrhythmias.
Disqualifiers
Patients undergoing combined cardiac procedures (e.g., valve repair or replacement).
Emergency CABG cases or re-operations.
Known bleeding disorders or ongoing anticoagulation therapy that cannot be paused.
Severe pericardial adhesions or anatomical abnormalities preventing safe creation of a posterior pericardial window.
Trial design
Treatments tested in this trial
- Not listed